“A Comprehensive Evaluation of the Transition to a Biosimilar of Adalimumab in Rheumatoid Arthritis and Psoriatic Arthritis: A Single-Center Experience With a Focus on Imaging Outcomes”. Reumatismo (May 8, 2025). Accessed June 1, 2025. https://www.reumatismo.org/reuma/article/view/1748.